MedPath

The Impact of Obesity on Nonsurgical Periodontal Therapy

Not Applicable
Conditions
Periodontitis
Periodontal Diseases
Obesity
Interventions
Drug: Placebo
Procedure: Scaling and root planning
Registration Number
NCT01405365
Lead Sponsor
Federal University of Rio Grande do Sul
Brief Summary

The purpose of this study is to investigate the effect that obesity may have on the nonsurgical treatment (with and without the adjunct use of metronidazole) of destructive periodontal diseases (chronic periodontitis).

Detailed Description

Normal weight (BMI 18.5-24.9 kg/m2) and obese (BMI \>30 kg/m2) women will be randomly assigned to two nonsurgical periodontal treatments:

1. scaling and root planing + placebo

2. scaling and root planing + metronidazole

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
96
Inclusion Criteria
  • Normal weight or obese (according to BMI)
  • nonsmokers or former smokers (3 or more years)
  • no systemic diseases that may affect periodontal treatment (diabetes, osteoporosis, steroid use)
  • have 10 teeth present
  • have at least 2 teeth with probing depth 6+mm and attachment loss 4+mm
Exclusion Criteria
  • Pregnancy
  • Development of diabetes or other conditions that may impair periodontal healing

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MetronidazoleMetronidazole-
MetronidazoleScaling and root planning-
PlaceboPlacebo-
PlaceboScaling and root planning-
Primary Outcome Measures
NameTimeMethod
Probing depth12 months

Defined as the distance from the free gingival margin to the bottom of the pocket/sulcus.

Secondary Outcome Measures
NameTimeMethod
Attachment level12 months

Defined as the distance from the CEJ to the bottom of the pocket/sulcus.

Trial Locations

Locations (1)

Universidade Federal do Rio Grande do Sul

🇧🇷

Porto Alegre, RS, Brazil

© Copyright 2025. All Rights Reserved by MedPath